KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Non-Current Deferred Tax Liability (2018 - 2022)

Historic Non-Current Deferred Tax Liability for Eli Lilly (LLY) over the last 11 years, with Q4 2022 value amounting to $4.6 billion.

  • Eli Lilly's Non-Current Deferred Tax Liability fell 897.69% to $4.6 billion in Q4 2022 from the same period last year, while for Dec 2022 it was $4.6 billion, marking a year-over-year decrease of 897.69%. This contributed to the annual value of $4.6 billion for FY2022, which is 897.69% down from last year.
  • Eli Lilly's Non-Current Deferred Tax Liability amounted to $4.6 billion in Q4 2022, which was down 897.69% from $171.9 million recorded in Q3 2022.
  • Over the past 5 years, Eli Lilly's Non-Current Deferred Tax Liability peaked at $5.1 billion during Q4 2020, and registered a low of $171.9 million during Q3 2022.
  • Its 5-year average for Non-Current Deferred Tax Liability is $2.6 billion, with a median of $2.2 billion in 2021.
  • In the last 5 years, Eli Lilly's Non-Current Deferred Tax Liability surged by 5161.16% in 2019 and then tumbled by 8947.01% in 2022.
  • Quarter analysis of 5 years shows Eli Lilly's Non-Current Deferred Tax Liability stood at $3.0 billion in 2018, then skyrocketed by 51.61% to $4.6 billion in 2019, then increased by 10.13% to $5.1 billion in 2020, then fell by 0.8% to $5.0 billion in 2021, then dropped by 8.98% to $4.6 billion in 2022.
  • Its last three reported values are $4.6 billion in Q4 2022, $171.9 million for Q3 2022, and $862.5 million during Q2 2022.